EP3496714 - DRUG COMPOSITIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.06.2024 Database last updated on 12.07.2024 | |
Former | Examination is in progress Status updated on 27.10.2023 | ||
Former | Request for examination was made Status updated on 17.05.2019 | ||
Former | The international publication has been made Status updated on 17.02.2018 | Most recent event Tooltip | 20.06.2024 | Application deemed to be withdrawn | published on 24.07.2024 [2024/30] | Applicant(s) | For all designated states DMK Pharmaceuticals Corporation 11682 El Camino Real, Suite 300 San Diego, CA 92130 / US | [2023/47] |
Former [2019/25] | For all designated states Adamis Pharmaceuticals Corporation 11682 El Camino Real, Suite 300 San Diego, CA 92130 / US | Inventor(s) | 01 /
SUTHERLAND, David, Clayton 301 Garden Valley Loop Little Rock, AR 72223 / US | 02 /
ZORN, James, Kyle 4588 Windstar Way Lexington, KY 40515 / US | 03 /
CARLO, Dennis, J. 11682 El Camino Real Suite 300 San Diego, CA 92130 / US | [2019/25] | Representative(s) | K&L Gates LLP Friedrichstraße 110 A 10117 Berlin / DE | [N/P] |
Former [2019/25] | K&L Gates LLP Markgrafenstrasse 42 10117 Berlin / DE | Application number, filing date | 17840369.7 | 11.08.2017 | [2019/25] | WO2017US46599 | Priority number, date | US201662373871P | 11.08.2016 Original published format: US 201662373871 P | [2019/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018031935 | Date: | 15.02.2018 | Language: | EN | [2018/07] | Type: | A1 Application with search report | No.: | EP3496714 | Date: | 19.06.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.02.2018 takes the place of the publication of the European patent application. | [2019/25] | Search report(s) | International search report - published on: | US | 15.02.2018 | (Supplementary) European search report - dispatched on: | EP | 19.03.2020 | Classification | IPC: | A61K31/4439, A61K31/4184, A61K9/10, A61K9/14, A61K47/38, A61K45/06, C08L1/28, A61P1/04 | [2020/17] | CPC: |
A61K31/4184 (EP,KR,US);
A61K9/0053 (KR);
A61K31/4439 (EP,KR,US);
A61K45/06 (EP,US);
A61K47/02 (KR);
A61K47/10 (KR);
A61K47/38 (EP,KR,US);
A61K9/0095 (KR);
A61K9/08 (KR);
A61K9/10 (EP,US);
A61K9/145 (EP,US);
A61K9/1641 (US);
A61K9/1652 (US);
A61P1/04 (EP,KR);
A61P33/10 (KR);
A61K2300/00 (US);
C01D5/14 (US);
C01D7/10 (US);
| C-Set: |
A61K31/4184, A61K2300/00 (US,EP);
A61K31/4439, A61K2300/00 (EP,US) |
Former IPC [2019/25] | A61K31/4439, A61K47/02, A61K47/18 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/25] | Title | German: | ARZNEIMITTELZUSAMMENSETZUNGEN | [2019/25] | English: | DRUG COMPOSITIONS | [2019/25] | French: | COMPOSITIONS DE MÉDICAMENTS. | [2019/25] | Entry into regional phase | 05.03.2019 | National basic fee paid | 05.03.2019 | Search fee paid | 05.03.2019 | Designation fee(s) paid | 05.03.2019 | Examination fee paid | Examination procedure | 05.03.2019 | Examination requested [2019/25] | 07.10.2020 | Amendment by applicant (claims and/or description) | 26.10.2023 | Despatch of a communication from the examining division (Time limit: M04) | 06.03.2024 | Application deemed to be withdrawn, date of legal effect [2024/30] | 27.03.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/30] | Fees paid | Renewal fee | 05.03.2019 | Renewal fee patent year 03 | 27.08.2020 | Renewal fee patent year 04 | 27.08.2021 | Renewal fee patent year 05 | 29.08.2022 | Renewal fee patent year 06 | 28.08.2023 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US6316481 (FREEHAUF KEITH [US]) [A] 1-14 * column 1, line 13 - line 21 * * column 1, line 46 - line 64 * * column 3, line 6 - line 15 *; | [A]EP2144599 (FARNAM CO INC [US]) [A] 1-14* claims 22, 23, 27, 28, 47, 50 * | International search | [Y]US2002065306 (PIPERS FRANK [US]) [Y] 19 * ; paragraphs [0012], [0045] *; | [XY]US2004037869 (CLEVERLY DOUGLAS [NZ], et al) [X] 1-3, 6-8, 10, 12-16, 20-25, 28-29, 31-32 * ; paragraphs [0008], [0010]-[0011], [0029]-[0040], [0053], [0098], [0185]-[0186], [0189], [0192], [0202]; claims 2, 17, 29-30, 41, 47 * [Y] 4-5, 9, 11, 17-19, 26-27, 30, 33; | [Y]US2005032719 (COTTRELL IAN [US], et al) [Y] 4-5, 9, 17-18, 26-27, 30 * ; paragraphs [0014], [0035], [0073] *; | [Y]US2012046319 (MOHAR BARBARA [SI], et al) [Y] 11 * ; paragraph [0117] *; | [Y]US2015057314 (PHILLIPS JEFFREY O [US]) [Y] 33* ; paragraphs [0090], [0102] * |